These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1647192)

  • 1. A competitive kinin receptor antagonist, [DArg0, Hyp3, DPhe7]-bradykinin, does not affect the response to nasal provocation with bradykinin.
    Pongracic JA; Naclerio RM; Reynolds CJ; Proud D
    Br J Clin Pharmacol; 1991 Mar; 31(3):287-94. PubMed ID: 1647192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bradykinin effects in guinea pig tracheal epithelial cells are mediated through a B2 kinin receptor and can be inhibited by the selective antagonist Hoe 140.
    Proud D; Reynolds CJ; Broomfield J; Goldman DW; Bathon JM
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1124-31. PubMed ID: 8383737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the action of bradykinin and bradykinin analogues in the human nasal airway.
    Austin CE; Foreman JC
    J Physiol; 1994 Jul; 478 ( Pt 2)(Pt 2):351-6. PubMed ID: 7965850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of mediator release from human skin mast cells upon stimulation by the bradykinin analog, [DArg0-Hyp3-DPhe7]bradykinin.
    Cohan VL; MacGlashan DW; Warner JA; Lichtenstein LM; Proud D
    Biochem Pharmacol; 1991 Jan; 41(2):293-300. PubMed ID: 1703413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bradykinin antagonist modifies allergen-induced mediator release and late bronchial responses in sheep.
    Abraham WM; Burch RM; Farmer SG; Sielczak MW; Ahmed A; Cortes A
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):787-96. PubMed ID: 2008991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of nasal provocation with bradykinin: studies of tachyphylaxis, cyclooxygenase inhibition, alpha-adrenergic stimulation, and receptor subtype.
    Churchill L; Pongracic JA; Reynolds CJ; Naclerio RM; Proud D
    Int Arch Allergy Appl Immunol; 1991; 95(4):322-31. PubMed ID: 1660035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction by Hoe 140, the B2 kinin receptor antagonist, of antigen-induced nasal blockage.
    Austin CE; Foreman JC; Scadding GK
    Br J Pharmacol; 1994 Apr; 111(4):969-71. PubMed ID: 8032622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bradykinin (BK)1 receptor antagonist blocks capsaicin-induced ear inflammation in mice.
    Mantione CR; Rodriguez R
    Br J Pharmacol; 1990 Mar; 99(3):516-8. PubMed ID: 1691948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of terfenadine and ipratropium bromide alone and in combination on bradykinin-induced nasal symptoms and plasma protein leakage.
    Rajakulasingam K; Polosa R; Lau LC; Church MK; Holgate ST; Howarth PH
    Clin Exp Allergy; 1992 Jul; 22(7):717-23. PubMed ID: 1387041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pain and inflammation evoked in human skin by bradykinin receptor antagonists.
    Kindgen-Milles D; Klement W
    Eur J Pharmacol; 1992 Jul; 218(1):183-5. PubMed ID: 1383008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on blood pressure of intracerebroventricular administration of a kinin antagonist.
    Yang XP; Carretero OA; Akahoshi M; Scicli AG
    Adv Exp Med Biol; 1989; 247A():439-45. PubMed ID: 2603810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the response to nasal provocation with bradykinin by HOE-140: efficacy and duration of action.
    Proud D; Bathon JM; Togias AG; Naclerio RM
    Can J Physiol Pharmacol; 1995 Jul; 73(7):820-6. PubMed ID: 8846415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of kinins in seasonal allergic rhinitis: icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen.
    Turner P; Dear J; Scadding G; Foreman JC
    J Allergy Clin Immunol; 2001 Jan; 107(1):105-13. PubMed ID: 11149999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-Arg[Hyp3-Thi5-D-Tic7-Tic8]-bradykinin, a potent antagonist of smooth muscle BK2 receptors and BK3 receptors.
    Farmer SG; Burch RM; Kyle DJ; Martin JA; Meeker SN; Togo J
    Br J Pharmacol; 1991 Apr; 102(4):785-7. PubMed ID: 1649657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of kinins in hyperresponsiveness induced by platelet activating factor in the human nasal airway.
    Turner PJ; Dear JW; Foreman JC
    Br J Pharmacol; 2000 Feb; 129(3):525-32. PubMed ID: 10711351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinin receptors of the central nervous system of spontaneously hypertensive rats related to the pressor response to bradykinin.
    Martins DT; Fior DR; Nakaie CR; Lindsey CJ
    Br J Pharmacol; 1991 Aug; 103(4):1851-6. PubMed ID: 1655143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of bradykinin receptor antagonists on antigen-induced respiratory distress, airway hyperresponsiveness and eosinophilia in guinea-pigs.
    Farmer SG; Wilkins DE; Meeker SA; Seeds EA; Page CP
    Br J Pharmacol; 1992 Nov; 107(3):653-9. PubMed ID: 1335332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of kinin receptor antagonists on renal hemodynamic and natriuretic responses to volume expansion.
    Fenoy FJ; Roman RJ
    Am J Physiol; 1992 Nov; 263(5 Pt 2):R1136-40. PubMed ID: 1332518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat.
    Proud D; Reynolds CJ; Lacapra S; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
    Am Rev Respir Dis; 1988 Mar; 137(3):613-6. PubMed ID: 3345041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo characterization of bradykinin B2 receptors in the rabbit and the guinea pig.
    Gobeil F; Filteau C; Pheng LH; Jukic D; Nguyen-Le XK; Regoli D
    Can J Physiol Pharmacol; 1996 Feb; 74(2):137-44. PubMed ID: 8723025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.